1. Is Indraprastha Medical Corporation Ltd a good quality company?
Past 10 year's financial track record analysis by Moneyworks4me indicates that Indraprastha Medical Corporation Ltd is a good quality company.
2. Is Indraprastha Medical Corporation Ltd undervalued or overvalued?
The key valuation ratios of Indraprastha Medical Corporation Ltd's currently when compared to its past seem to suggest it is in the Fair zone.
3. Is Indraprastha Medical Corporation Ltd a good buy now?
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Indraprastha Medical Corporation Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation ⓘ
Value Creation Index Colour Code Guide ⓘ
|ROCE % ⓘ||14.8%||17.1%||15.4%||11.6%||11.2%||9.5%||12.2%||18.1%||1.9%||21.8%||-|
|Value Creation Index ⓘ||0.1||0.2||0.1||-0.2||-0.2||-0.3||-0.1||0.3||-0.9||0.6||-|
Growth Parameters ⓘ
Growth Parameters Colour Code Guide ⓘ
|YoY Gr. Rt. %||-||11.7%||5.4%||5.7%||1.4%||-1.7%||4.7%||5.4%||-26.2%||44.8%||-|
|Adj EPS ⓘ||3.1||3.9||3.6||2.7||2.9||2.4||3.2||4.8||0.3||6.8||6.9|
|YoY Gr. Rt. %||-||23.6%||-8.5%||-22.8%||6.2%||-17.2%||33.2%||50.8%||-93.6%||2106.5%||-|
|BVPS (₹) ⓘ||18.7||20.4||21.3||24.4||25.2||25.3||26.6||29.2||29.8||35.5||37.7|
|Adj Net Profit ⓘ||28.7||35.6||32.5||25.1||26.6||22.1||29.4||44.3||2.8||62.7||63|
|Cash Flow from Ops. ⓘ||66.9||58.1||64.3||62.3||27.6||47.7||75.2||86.5||26.8||71.3||-|
|Debt/CF from Ops. ⓘ||1.1||1.1||0.8||0.8||2.4||1.4||0.3||0.1||0||0||-|
CAGR Colour Code Guide ⓘ
|9 Years||5 Years||3 Years||1 Years|
|Adj EPS ⓘ||9%||18.6%||28.7%||2106.5%|
Key Financial Parameters ⓘ
Performance Ratio Colour Code Guide ⓘ
|Return on Equity % ⓘ||17.4||19.9||17||12||11.7||9.5||12.4||17.3||1.1||21||18.9|
|Op. Profit Mgn % ⓘ||13||13.4||11.9||10.6||10.4||9.9||10.4||10.5||6.7||13.5||12.8|
|Net Profit Mgn % ⓘ||4.7||5.3||4.6||3.3||3.5||2.9||3.7||5.3||0.5||7.1||6.7|
|Debt to Equity ⓘ||0.4||0.3||0.3||0.2||0.3||0.3||0.1||0||0||0||-|
|Working Cap Days ⓘ||77||76||75||72||73||69||59||53||71||48||0|
|Cash Conv. Cycle ⓘ||1||0||-4||-6||-5||1||-3||-13||-15||-16||0|
Return on Equity has increased versus last 3 years average to 18.90%
Net Profit is growing at healthy rate in last 3 years 28.68%
Sales growth is good in last 4 quarters at 33.80%
Sales growth has been subdued in last 3 years 4.06%
|TTM EPS (₹)||6.9||-|
|TTM Sales (₹ Cr.)||949||-|
|BVPS (₹.) ⓘ||37.7||-|
|Reserves (₹ Cr.) ⓘ||254||-|
|From the Market|
|52 Week Low / High (₹)||52.00 / 87.45|
|All Time Low / High (₹)||4.00 / 102.55|
|Market Cap (₹ Cr.)||602|
|Equity (₹ Cr.)||91.7|
|Face Value (₹)||10|
|Industry PE ⓘ||65|
Indraprastha Medical Corporation (Indraprastha) was incorporated as public limited company on March 16,1988 with the ROC and obtained the certificate of commencement of business on April 7,1988.It is a Delhi-based healthcare company which operates through Indraprastha Apollo Hospital. Indraprastha Apollo, a 695 bed specialty hospital, was commissioned on December 1995 in collaboration with New Delhi administration. The hospital, spread across an area of 675,000 sq ft, is the largest corporate hospital in India and the fourth largest in the world. The hospital has various centres such as Apollo cardiac center, Apollo cancer center and Apollo surgical science center, among others. The company has operated on around 7.4 million patients. The group also owns 12 hospitals and four clinics. It is running a multi super-specialty hospital.
Business area of the company :
It offers a range of diagnostic, medical, and surgical facilities for the care of its patients. The company provides treatments in the areas of anaesthesiology, oncology, cardiology, neurology, orthopedics, nephrology, ophthalmology, nuclear medicine, pediatrics, physiotherapy and rehabilitation, psychiatry and psychology, radiology, urology and andrology, gastroenterology, gynecology and obstetrics, dermatology, dietetics and nutrition, and respiratory and sleep medicine. It also offers various surgical services, including dental, cardiothoracic, neuro, vascular, joint, plastic and cosmetic, and general surgeries. In addition, the companyâ€™s diagnostic services include lab services, radio-diagnosis, nuclear medicine, endoscopy lab, bronchoscopy lab, and blood bank. Further, it offers ambulance and air ambulance services, as well as out patient consultation services.
As of March 31, 2009, Indraprastha Apollo Hospitals performed around 2000 cardiac surgeries, 400 joint replacements, 1000 onco surgeries, 90 liver transplants and 135 renal transplants. The company's hospitals are located in Chennai, Hyderabad, Kolkata, Ahmedabad, Bangalore, Bilaspur and Madurai.
Indraprastha Medical Corporation plans to set up more than ten satellite clinics in and around Delhi to facilitate easy availability of Apollo-type medical services to a larger cross-section of society. These clinics are to take the shape of mini-hospitals with all basic back-up emergency services mainly aimed at providing post-treatment facilities to Apollo Hospitals patients. Each clinic would cost between Rs 10 to Rs 15 million. It also plans to acquire some of the existing small clinics situated at various locations, upgrade them and start as Apollo clinics.